Anti-NMDA receptor encephalitis risk factors

Anti-NMDA receptor encephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Anti-NMDA receptor encephalitis from Other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Anti-NMDA receptor encephalitis risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Anti-NMDA receptor encephalitis risk factors
CDC on Anti-NMDA receptor encephalitis risk factors
Anti-NMDA receptor encephalitis risk factors in the news
Blogs on Anti-NMDA receptor encephalitis risk factors
Directions to Hospitals Treating Anti-NMDA receptor encephalitis
Risk calculators and risk factors for Anti-NMDA receptor encephalitis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]

Overview

Risk factors for anti-NMDA encephalitis include female predominance, higher incidence in young individuals, and increased likelihood of underlying teratoma in African-Americans and teratomas in Asians.

Risk Factors

The risk factors include females preponderance, the high incidence of the disease in youngsters, and the increased likelihood of an underlying teratoma among African-Americans. Asian patients had a higher incidence of teratomas.